120 Capital is a venture fund focused on life‑science and healthcare companies developing breakthrough therapeutics, platforms, and medical technologies. The firm backs innovative biotech, digital health, and med‑device ventures that address unmet medical needs and have the potential for global impact. It leverages deep industry expertise and networks to help portfolio companies advance from early clinical stages to commercialization.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
46.2%United Kingdom
23.1%Venezuela
7.7%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Series A → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year